Literature DB >> 21507633

The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.

Yibin Xiang1, Bradford Hirth, Gary Asmussen, Hans-Peter Biemann, Kimberly A Bishop, Andrew Good, Maria Fitzgerald, Tatiana Gladysheva, Annuradha Jain, Katherine Jancsics, Jinyu Liu, Markus Metz, Andrew Papoulis, Renato Skerlj, J David Stepp, Ronnie R Wei.   

Abstract

Novel benzofuran-2-carboxylic acids, exemplified by 29, 38 and 39, have been discovered as potent Pim-1 inhibitors using fragment based screening followed by X-ray structure guided medicinal chemistry optimization. The compounds demonstrate potent inhibition against Pim-1 and Pim-2 in enzyme assays. Compound 29 has been tested in the Ambit 442 kinase panel and demonstrates good selectivity for the Pim kinase family. X-ray structures of the inhibitor/Pim-1 binding complex reveal important salt-bridge and hydrogen bond interactions mediated by the compound's carboxylic acid and amino groups.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507633     DOI: 10.1016/j.bmcl.2011.03.030

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  Expedited Synthesis of Benzofuran-2-Carboxylic Acids via Microwave-Assisted Perkin Rearrangement Reaction.

Authors:  Karla-Sue C Marriott; Rena Bartee; Andrew Z Morrison; Leonard Stewart; Julian Wesby
Journal:  Tetrahedron Lett       Date:  2012-04-24       Impact factor: 2.415

2.  Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.

Authors:  Mustapha Haddach; Jerome Michaux; Michael K Schwaebe; Fabrice Pierre; Sean E O'Brien; Cosmin Borsan; Joe Tran; Nicholas Raffaele; Suchitra Ravula; Denis Drygin; Adam Siddiqui-Jain; Levan Darjania; Ryan Stansfield; Chris Proffitt; Diwata Macalino; Nicole Streiner; Joshua Bliesath; May Omori; Jeffrey P Whitten; Kenna Anderes; William G Rice; David M Ryckman
Journal:  ACS Med Chem Lett       Date:  2011-12-27       Impact factor: 4.345

3.  Identification of quinones as novel PIM1 kinase inhibitors.

Authors:  Richard L Schroeder; Navneet Goyal; Melyssa Bratton; Ian Townley; Nancy A Pham; Phan Tram; Treasure Stone; Jasmine Geathers; Kathy Nguyen; Jayalakshmi Sridhar
Journal:  Bioorg Med Chem Lett       Date:  2016-04-28       Impact factor: 2.823

4.  Identification of novel inhibitors for Pim-1 kinase using pharmacophore modeling based on a novel method for selecting pharmacophore generation subsets.

Authors:  Rand Shahin; Lubna Swellmeen; Omar Shaheen; Nour Aboalhaija; Maha Habash
Journal:  J Comput Aided Mol Des       Date:  2015-12-19       Impact factor: 3.686

5.  Fragment screening of cyclin G-associated kinase by weak affinity chromatography.

Authors:  Elinor Meiby; Stefan Knapp; Jonathan M Elkins; Sten Ohlson
Journal:  Anal Bioanal Chem       Date:  2012-08-24       Impact factor: 4.142

6.  Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach.

Authors:  Mingfeng Shao; Yiming Yuan; Kun Yu; Kai Lei; Guonian Zhu; Lijuan Chen; Mingli Xiang
Journal:  Mol Divers       Date:  2014-02-12       Impact factor: 2.943

7.  Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design.

Authors:  Ola Fjellström; Sibel Akkaya; Hans-Georg Beisel; Per-Olof Eriksson; Karl Erixon; David Gustafsson; Ulrik Jurva; Daiwu Kang; David Karis; Wolfgang Knecht; Viveca Nerme; Ingemar Nilsson; Thomas Olsson; Alma Redzic; Robert Roth; Jenny Sandmark; Anna Tigerström; Linda Öster
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

8.  Structural analysis of PIM1 kinase complexes with ATP-competitive inhibitors.

Authors:  Jozefina Bogusz; Karol Zrubek; Krzysztof P Rembacz; Przemyslaw Grudnik; Przemyslaw Golik; Malgorzata Romanowska; Benedykt Wladyka; Grzegorz Dubin
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

9.  Synthesis of new pyridothienopyrimidinone derivatives as Pim-1 inhibitors.

Authors:  Bassem H Naguib; Hala B El-Nassan; Tamer M Abdelghany
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

10.  Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies.

Authors:  Wagdy M Eldehna; Sara T Al-Rashood; Tarfah Al-Warhi; Razan O Eskandrani; Amal Alharbi; Ahmed M El Kerdawy
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.